Literature DB >> 25057862

Neuro-oncology: a selected review of ASCO 2012 abstracts.

Marc C Chamberlain1.   

Abstract

The American Society of Clinical Oncology (ASCO), the largest clinical oncology meeting in the USA, meets annually and reproducibly provides an exciting forum to present new cancer clinical trials and research data. The ASCO 2012 CNS tumors section comprised 3 days of presentations and over 130 abstracts, providing an overview of neuro-oncology, including both metastatic diseases of the CNS and primary brain tumors. This brief review attempts to highlight select abstracts presented at this year's meeting in an organized manner that will provide a portrait of a large and multifaceted meeting.

Entities:  

Mesh:

Year:  2012        PMID: 25057862      PMCID: PMC6176815          DOI: 10.2217/cns.12.24

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  1 in total

1.  Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.

Authors:  Mary Lou Affronti; Jennifer Gamboa Jackman; Frances McSherry; James E Herndon; Elwood C Massey; Eric Lipp; Annick Desjardins; Henry S Friedman; Gordana Vlahovic; James Vredenburgh; Katherine B Peters
Journal:  Oncologist       Date:  2018-04-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.